Nico.Lab B.V.

Paasheuvelweg 25, 1105 BP, Amsterdam, The Netherlands All Netherlands companies → — Founded 2015

Imaging AI Specialist Specialty-Focused AI

Emergency Medicine Neurology Radiology

Neurology AI Radiology & Imaging AI Triage & ER/ICU AI

Pre-IPO, Grant

Claim this company

About Nico.Lab B.V.

Nico.Lab B.V. is a medical technology company specializing in artificial intelligence (AI) solutions for acute stroke care. Their flagship product, StrokeViewer, is an AI-powered platform designed to assist physicians in making rapid and accurate treatment decisions for stroke patients. StrokeViewer analyzes medical images, such as CT scans, to provide quantitative insights into brain damage and assess the treatability of a stroke. This includes identifying large vessel occlusions, quantifying infarct core and penumbra volumes, and providing perfusion maps. The platform aims to streamline the diagnostic workflow, reduce time to treatment, and ultimately improve patient outcomes by facilitating faster and more informed clinical decisions.

The technology developed by Nico.Lab integrates seamlessly into existing hospital imaging infrastructure, providing physicians with critical information at the point of care. By automating and enhancing the analysis of complex imaging data, StrokeViewer helps to standardize stroke assessment and reduce inter-observer variability. The system is designed to support clinicians in identifying eligible patients for advanced stroke therapies, such as mechanical thrombectomy, which are highly time-sensitive. Nico.Lab’s focus is on leveraging AI to optimize the entire stroke care pathway, from initial diagnosis to treatment planning, thereby empowering healthcare professionals with advanced tools to combat the devastating effects of stroke.

Focus Areas

acute stroke care artificial intelligence medical imaging analysis clinical decision support workflow optimization large vessel occlusion detection interhospital communication

Business Intelligence

Technology

cloud-native, Google Cloud (Compute Engine, Cloud Firestore, Cloud Pub/Sub, Cloud Storage, Cloud VPN, Kubernetes Engine, Cloud Healthcare API), TensorFlow

What Physicians Need to Know

Acute Stroke Imaging & Triage

Specializes in rapid analysis of CT and MR perfusion scans to identify salvageable brain tissue (penumbra) and core infarct, crucial for timely thrombectomy decisions. Provides automated stroke lesion detection and quantification.

Clinical AI for Medical Imaging

Develops AI algorithms specifically trained on large datasets of medical images to assist in the diagnosis and management of time-sensitive conditions like stroke, aortic dissection, and pulmonary embolism. Focuses on improving diagnostic accuracy and speed.

CT & MR Perfusion Analysis

Offers advanced, automated software for quantitative analysis of CT and MR perfusion studies, generating detailed maps of cerebral blood flow, blood volume, and mean transit time. This is critical for stroke treatment stratification.

Image Sharing & Telemedicine

Facilitates secure and efficient sharing of medical images and reports between healthcare providers, enabling remote consultations and collaborative decision-making, particularly vital for hub-and-spoke stroke networks.

PACS/DICOM Integration

Seamlessly integrates with existing Picture Archiving and Communication Systems (PACS) and adheres to DICOM standards, ensuring compatibility and smooth workflow integration within hospital IT infrastructures.

AI-based Image Triage & Alerting

Utilizes AI to automatically prioritize critical cases requiring immediate attention, sending real-time alerts to physicians. This reduces time-to-diagnosis and treatment for emergent conditions.

Aortic Dissection & Pulmonary Embolism

Extends AI capabilities beyond stroke to include automated detection and analysis for other critical conditions like aortic dissection and pulmonary embolism, aiding in rapid diagnosis and management.

Key Differentiators

Focus on acute, time-sensitive conditions; comprehensive perfusion analysis; real-time AI-driven alerts; seamless PACS integration; broad application across multiple critical pathologies (stroke, AD, PE).

Technology Stack

Leverages advanced machine learning and deep learning algorithms, cloud-based infrastructure for scalability, and robust DICOM processing engines for image handling and analysis.

Physician Tip

For physicians, Nico.Lab B.V. offers critical tools to accelerate diagnosis and treatment decisions in acute stroke and other emergent conditions. The AI-driven triage and real-time alerts can significantly reduce door-to-needle/groin times. Automated perfusion analysis provides objective, quantitative data to guide thrombectomy decisions, potentially improving patient outcomes. The system's ability to integrate seamlessly into existing PACS workflows minimizes disruption, while secure image sharing facilitates rapid consultation with specialists, especially in telemedicine scenarios. This technology aims to reduce diagnostic variability and physician workload by automating routine but critical image analysis tasks.

Nico.Lab B.V. emphasizes robust PACS/DICOM integration, ensuring compatibility with most hospital imaging systems. This allows for automated image transfer, processing, and return of results directly into the physician's workflow. The system is designed to be vendor-neutral, facilitating integration into diverse IT environments without significant infrastructure overhaul. Telemedicine platforms are also supported for enhanced remote collaboration.

Products by Nico.Lab B.V.

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

Nico.Lab B.V. appears to be a company with a strong focus on medical imaging software, particularly for stroke diagnostics. Reviews suggest their products are innovative and contribute positively to patient care, though some users note a learning curve. As an employer, information is scarce, but the company culture seems to be driven by its mission.

Overall: Positive

Strengths

Innovative medical imaging software
Positive impact on patient care (e.g., stroke diagnostics)
User-friendly interface (after initial learning)
Strong focus on product development
Potential for significant clinical value

Limitations

Limited public information on employer reviews
Potential learning curve for new users
Specific product details and pricing not readily available in public reviews
Lack of diverse review platforms for comprehensive feedback
Specific customer support experiences not widely detailed

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT News/Review Sites, Reddit

Last updated: 2026-10-17

Videos

News, demos, and interviews about Nico.Lab B.V..

Loading videos...

Videos load interactively. If none appear, search YouTube for Nico.Lab B.V. →

View all on YouTube

Press & Coverage

PRNewswire

NICO.LAB Ready to Revolutionize U.S. Stroke Care After FDA Clearance

Nico.Lab received FDA clearance for its StrokeViewer LVO, an AI algorithm for fast triaging of stroke patients, enabling quicker diagnosis and treatment in the U.S.

2020-11

AuntMinnie.com

FDA OKs Nico.Lab's AI stroke software

The FDA cleared Nico.Lab's StrokeViewer LVO, an AI algorithm that detects large vessel occlusions, allowing medical specialists to inspect CT images remotely via smartphones.

2020-11

NeuroNews International

NICO.LAB receives FDA clearance for AI stroke care solution

Nico.Lab's StrokeViewer LVO received FDA clearance, an AI-powered solution designed for rapid triaging of stroke patients by detecting large vessel occlusions.

2020-12

EINPresswire.com

Nico.Lab Raises AU$13 Million in Pre-IPO Investment Round

Nico.Lab closed an AU$13 million Pre-IPO funding round led by Canaccord Genuity Australia to accelerate AI solution development and international growth.

2021-04

Medical Device Network

Philips partners with NICO.LAB to enhance stroke care

Royal Philips partnered with Nico.Lab to integrate StrokeViewer into its stroke care solutions, aiming to streamline workflows and improve patient outcomes.

2021-07

Nicolab (Press Release)

Nicolab and Carahsoft Partner to Bring AI-Powered Stroke Workflow Solutions to the Public Sector

Nico.Lab partnered with Carahsoft Technology Corp. to make its StrokeViewer platform available to the U.S. Public Sector, including VA and IHS facilities.

2026-08

Nicolab (Press Release)

Nicolab strengthens leadership as it accelerates towards 2027 ASX listing

Nico.Lab appointed Charlie Bell as CEO and Managing Director as the company accelerates towards a 2027 ASX listing.

2026-09

Nicolab (Press Release)

Nicolab Expands Access to Life-Saving Stroke AI Through New Partnership with Harrison.ai

Nico.Lab joined the Harrison.ai Open Platform as a launch partner to increase accessibility of its FDA-approved StrokeViewer AI solution.

2026-09

Frequently Asked Questions

What are Nico.Lab's primary products for acute stroke imaging and triage, and how do they utilize AI?

Nico.Lab's flagship product is StrokeViewer, an AI-powered clinical decision support system designed for rapid assessment of imaging biomarkers in acute stroke. It provides automated analysis of CT/MR perfusion, AI-based detection of ICH and LVO, and mobile diagnostic viewing to improve stroke care workflows.

How does Nico.Lab's technology support CT and MR perfusion analysis for stroke patients?

Nico.Lab's platform offers automated analysis of both CT and MR perfusion images, providing critical insights such as ischemic core and penumbra quantification, multicolored perfusion maps, and core/mismatch volume assessment. This helps clinicians make timely, informed treatment decisions regardless of the imaging protocol used.

Beyond stroke, what other acute conditions, such as Aortic Dissection or Pulmonary Embolism, does Nico.Lab's AI address?

Nico.Lab has expanded its AI portfolio beyond stroke to include solutions for acute Aortic Dissection and Pulmonary Embolism through Nicolab Assist and collaborations with third-party AI systems like Avicenna and CINA. These solutions are designed to identify urgent cases, flag findings, and provide real-time alerts to care teams.

How do Nico.Lab's solutions integrate with existing hospital systems like PACS/DICOM, and what image sharing and telemedicine capabilities do they offer?

Nico.Lab's cloud-native solutions offer seamless PACS/DICOM integration, allowing for secure transfer and access to full DICOM series from any device. The platform includes telemedicine collaboration tools such as real-time screen sharing, secure in-app messaging, and instant notifications to facilitate inter-hospital communication and remote diagnosis.

What regulatory compliance and data security measures does Nico.Lab have in place for its medical imaging AI?

Nico.Lab's StrokeViewer LVO and CT Perfusion algorithms have received FDA 510(k) clearance, and their products are also CE marked and TGA approved, demonstrating compliance with international medical device regulations. The platform adheres to data security and privacy standards such as GDPR and HIPAA, with patient data encrypted both at rest and in transit.

What kind of support and training does Nico.Lab provide to healthcare facilities, and what is their approach to partnerships?

Nico.Lab offers dedicated customer support, including 24/7 ongoing multi-lingual assistance, customized training (live, virtual, or on-demand), and custom reporting. They engage in strategic partnerships with academic medical centers, clinical groups, and technology companies like Philips and Health New Zealand to expand global access and integrate their AI solutions into broader acute care pathways.

Can you provide information on Nico.Lab's company stability and general pricing model?

Nico.Lab, founded in 2015 as a spin-off from Amsterdam UMC, is an Australian-based publicly unlisted company with an expanding global presence and a team of 21-58 employees. While specific pricing models are not publicly detailed, their cloud-based, software-as-a-service (SaaS) approach suggests a subscription-based model, aiming for easy implementation without additional hardware.

Related Companies

Suggest an Edit → | Report an issue